Furthermore, the combination of RASSF1A and p16 methylation markers give good discrimination between NPC and non-NPC samples, although better results could be obtained by combining five methylation markers (RASSF1A, p16, WIF1, CHFR, and RIZ1) [49]. This evidence concerns the gene CDKN2A and nasopharyngeal carcinoma.